Physician profile
Dennis Nelson Smith
NPI 1871697052
$12,717.74
in general payments reported to CMS, 2019-2025
49 companies · $2,087 in 2025
The $2,087 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2020: $778 · 2021: $1,714 · 2022: $2,432 · 2023: $2,701 · 2024: $1,898 · 2025: $2,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,648 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,647.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,136.61 | 2021-2025 | Interstim, Altaviva |
| Sumitomo Pharma America, INC. | $1,383.66 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $1,021.34 | 2020-2025 | Urolift |
| Boston Scientific Corporation | $682.84 | 2019-2024 | Ams 700, Solyx Sis System, Rezum Generator |
| Medtronic USA, INC. | $657.81 | 2019-2020 | |
| Procept Biorobotics Corporation | $638.14 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Antares Pharma, INC. | $565.72 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $489.52 | 2019-2024 | Myrbetriq, Veozah |
| Endo Pharmaceuticals INC. | $434.28 | 2019-2024 | Xiaflex, Aveed, Edex |
| Urovant Sciences INC | $350.29 | 2021-2022 | |
| Urogen Pharma, INC. | $273.66 | 2021-2025 | Jelmyto |
| Accord Healthcare, INC. | $261.18 | 2022-2025 | |
| Janssen Biotech, INC. | $235.27 | 2019-2024 | Erleada |
| Endo USA, INC. | $207.06 | 2024-2025 | Xiaflex, Aveed |
| Halozyme INC | $189.66 | 2023 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $183.30 | 2019-2020 | |
| Amgen INC. | $173.18 | 2020-2022 | |
| Axonics, INC. | $172.87 | 2021-2024 | Bulkamid |
| Abbvie INC. | $161.65 | 2019-2024 | Botox |
| Verity Pharmaceuticals INC. | $150.29 | 2024-2025 | Trelstar, Tlando |
| Myriad Genetic Laboratories, INC. | $131.61 | 2022 | |
| Olympus America INC. | $123.56 | 2025 | Itind System |
| Merck Sharp & Dohme LLC | $121.08 | 2022-2024 | Welireg, Keytruda, Lynparza |
| Vertex Pharmaceuticals Incorporated | $111.49 | 2024-2025 | |
| Myovant Sciences INC. | $91.36 | 2022 | |
| 180 Medical, INC. | $70.95 | 2019-2020 | |
| Bioprotect Medical, INC. | $65.72 | 2024-2025 | Bioprotect Balloon Implant System |
| Ferring Pharmaceuticals INC. | $63.19 | 2019-2025 | Adstiladrin |
| E.R. Squibb & Sons, L.L.C. | $62.13 | 2022 | |
| Novartis Pharmaceuticals Corporation | $47.72 | 2021-2025 | |
| Blue Earth Diagnostics | $47.13 | 2021 | |
| Calyxo, INC. | $42.16 | 2024-2025 | Cvac Aspiration System |
| Kowa Pharmaceuticals America, INC. | $41.04 | 2022 | |
| Zyla Life Sciences, INC. | $36.44 | 2019-2020 | |
| Emd Serono, INC. | $36.24 | 2020-2021 | |
| Clarus Therapeutics INC. | $32.42 | 2021 | |
| Coloplast Corp | $30.04 | 2021-2024 | |
| Allergan, INC. | $26.68 | 2019-2021 | |
| Hologic Sales and Service, LLC | $24.23 | 2023 | Omni Hysteroscope, Novasure, Fluent Fluid Management System |
| Dendreon Pharmaceuticals LLC | $23.63 | 2025 | Provenge |
| Azurity Pharmaceuticals, INC. | $20.29 | 2025 | Azmiro |
| Immunitybio, INC. | $19.22 | 2025 | |
| Acacia Pharma INC | $16.10 | 2021 | |
| Rochester Medical Corporation | $14.58 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.42 | 2021 | |
| Dentsply Ih INC. | $12.16 | 2020 | |
| Baudax Bio INC. | $11.91 | 2021 | |
| Mission Pharmacal Company | $11.91 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,770.18 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.